Ann: Bit225 Covid-19 Human Study Commenced, page-143

Assuming your right about the long term drag of Covid, which seems realistic given what we know, and assuming that BIT225 is ultimately shown to be of benefit which is a possibility, there is still an ocean to cross in the Biotron canoe to get the idea to the market and herein being the problem.

Any rational debate considers not just if the idea is a good one but also if the people who have the idea have the ability to get it there. This is the primary downside of Biotron IMHO. If you place BIT management next to a glacier some might observe that the glacier is moving.

Even though BIT225 existed decades before the pandemic and had already progressed through dosing and basic safety trials in various contexts and therefore it has been argued that Biotron had a running start at this. So after 2.5 years of pandemic panic and "unprecedented" (people love that word) public and private funding what has Biotron achieved on this front?

Despite the headstart Biotron have only managed to inject a couple of dozen covid infected mice. The ones that didn't die were obviously quite happy but unlike dozens of other companies Biotron still haven't managed a proper human trial and seem hesitant to allocate resources towards doing so.

The company made lot of noise about seeking FDA feedback on trial design etc but then announced a half baked trial which by its very nature of bolting it onto the closing phases of an existing trial make it extremely high risk of having low to no credibility. There has been absolutely nothing stopping the company doing a quick CR many months back to fund a proper Covid trial but they have specifically chosen not to.

Biotron's own actions of late send a clear message to the market that they are not prioritizing Covid R&D. The 2.5 years of glacial drift shows little more than lip service to covid.

The company's actions show HIV is Biotron's sole focus. I think there is a good reason for that. Mid 2023 could be good for Biotron but there is no evidence that management are making any real effort on the Covid front at all. Just lip service.